EDAP TMS Franceis a lyonbiopole member

General information

4 rue du Dauphiné

69120 Vaulx-en-Velin

Incorporated in: 1994/05/06

Number of employees: 190

Turnover: €35M (in 2016)

More information


Main activity

Global leader in therapeutic ultrasound and present in the market for more than 35 years, EDAP TMS (NASDAQ: EDAP) develops, manufactures, promotes and distributes worldwide minimally-invasive medical devices for urology using ultrasound technology. By combining the latest technologies in imaging and treatment modalities in its complete range of Robotic HIFU devices, EDAP TMS introduced the Focal One as the answer to all requirements for ideal focal therapy of prostate cancer as a complement to the existing Ablatherm HIFU. As a pioneer and key player in the field of extracorporeal lithotripsy (ESWL), EDAP TMS exclusively utilized the latest generation of shock wave source in its Sonolith range of ESWL systems.


Public funding obtained: FUI : 91 K€ / 3 years / 2013 FUI : 1,4 M€ / 3 years / 2011 OSEO : 300 K€ / 3 years /2008 ANR : 212 K€ / 3 years / 2010 OSEO : 65 K€ / 3 years /2008

Stock exchange listing: EDAP TMS SA (Holding) is listed on NASDAQ market in New York since 1997.

Products / Services / Technologies

Strategic area of application
Human Medicine

Application market

Medical device

By continuing your navigation on our site, you accept the use of cookies and the collection of your data and personal information by Lyonbiopôle, for the purposes of measuring the traffic on the website, to provide statistics and to offer you adapted content to your centers of interest. To exercise your rights of access, rectification, opposition, deletion and portability, in accordance with the General Data Protection Regulation (EU 2016/679), you are informed that you can send your request to dpo@lyonbiopole.com. More details are available by clicking here I agree